Mark Rothera is the founder of Silence Therapeutics. Silence Therapeutics has raised $120M in total funding. Latest round: Series B.
Mark Rothera is an industry veteran with 30+ years of biopharma leadership experience. He has a strong reputation for driving the successful scale-up of multiple biotech companies, focusing much of his career on specialty diseases and novel modalities including gene therapy and RNAi therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide